Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Sotorasib |
Trade Name | Lumakras |
Synonyms | AMG 510|AMG510|AMG-510|Lumykras |
Drug Descriptions |
Lumakras (sotorasib) is small molecule inhibitor that selectively targets KRAS G12C and inhibits downstream signaling, which may lead to growth inhibition of tumors harboring KRAS G12C (PMID: 31666701). Lumakras (sotorasib) is FDA approved for use in patients with locally advanced or metastatic non-small cell lung cancer harboring KRAS G12C who have received one or more prior therapy (FDA.gov). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | 2252403-56-6 |
NCIT ID | C154287 |